| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI115607 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC442874 |
| https://europepmc.org/articles/PMC442874?pdf=render | ||
| P932 | PMC publication ID | 442874 |
| P698 | PubMed publication ID | 1371124 |
| P5875 | ResearchGate publication ID | 21784836 |
| P2093 | author name string | M. J. Karnovsky | |
| E. R. Edelman | |||
| L. T. Smith | |||
| M. A. Nugent | |||
| P2860 | cites work | Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) | Q24634292 |
| Recent developments in the cell biology of basic fibroblast growth factor | Q24679568 | ||
| Angiogenic factors | Q29620582 | ||
| Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury | Q33564406 | ||
| Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury | Q33584566 | ||
| Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries | Q34254075 | ||
| Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix | Q34613112 | ||
| Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor | Q34617842 | ||
| A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane | Q35818217 | ||
| Endothelial regeneration. VII. Lack of intimal proliferation after defined injury to rat aorta | Q35834995 | ||
| Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration | Q36900227 | ||
| Basic fibroblast growth factor induces angiogenesis in vitro | Q37401185 | ||
| Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation | Q37926154 | ||
| Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia | Q38253045 | ||
| The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
| Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules | Q38345199 | ||
| Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. | Q38629840 | ||
| Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates | Q39168466 | ||
| Vasculature in the walls of human coronary arteries | Q41242824 | ||
| Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis | Q41543829 | ||
| Controlled and modulated release of basic fibroblast growth factor | Q41667530 | ||
| Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110. | Q42752561 | ||
| Development of intimal lesions after leukocyte migration into the vascular wall. | Q42768948 | ||
| Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit | Q44222268 | ||
| Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells | Q44964513 | ||
| Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth | Q45849611 | ||
| Fibroblast growth factor: structural and biological properties. | Q46870869 | ||
| Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. | Q50927284 | ||
| Role of basic fibroblast growth factor in vascular lesion formation | Q56428189 | ||
| An in vivo model for study of the angiogenic effects of basic fibroblast growth factor | Q56428784 | ||
| Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular response | Q56428985 | ||
| Suppression by heparin of smooth muscle cell proliferation in injured arteries | Q59085680 | ||
| Effects of class I heparin binding growth factor and fibronectin on platelet adhesion and aggregation | Q67658348 | ||
| Vasoconstriction: a new activity for platelet-derived growth factor | Q68794635 | ||
| Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment | Q68838884 | ||
| Heparin protects basic and acidic FGF from inactivation | Q68895706 | ||
| Site-directed neovessel formation in vivo | Q69037870 | ||
| Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted | Q69061239 | ||
| Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form | Q69208934 | ||
| The fate of intravenously administered bFGF and the effect of heparin | Q69447125 | ||
| Acidic fibroblast growth factor enhances peripheral nerve regeneration in vivo | Q69620199 | ||
| Controlled release and magnetically modulated systems for macromolecular drugs | Q69898832 | ||
| Relation between arterial intimal thickening and the vasa-vasorum | Q69948184 | ||
| Reaction of the aortic wall of the rabbit after superficial, longitudinal, mechanical trauma | Q70114805 | ||
| High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells | Q70175493 | ||
| Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium | Q70239386 | ||
| Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium | Q70697552 | ||
| Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin | Q71156291 | ||
| Intimal vascularization and atherosclerosis | Q75773697 | ||
| Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury | Q93514193 | ||
| Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit | Q93521465 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 465-473 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries | |
| P478 | volume | 89 |
| Q73486413 | Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury |
| Q42391720 | Adventitia as a target for intravascular local drug delivery |
| Q58492262 | Adventitial vasa vasorum in balloon-injured coronary arteries |
| Q34150587 | Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease |
| Q41338703 | Angiogenesis in ischemic heart disease |
| Q40878997 | Angiogenesis in the pathobiology and treatment of vascular and malignant diseases. |
| Q42123857 | Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury |
| Q38073476 | Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression |
| Q73874731 | Anti-angiogenic drug AGM1470 suppresses smooth muscle cell migration induced by endothelial PDGF |
| Q72072734 | Antiangiogenesis: A suitable preventive treatment of restenosis |
| Q34133039 | Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model |
| Q38326202 | Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo |
| Q34150085 | Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model |
| Q42810785 | Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate |
| Q28577381 | Basic fibroblast growth factor decreases elastin gene transcription in aortic smooth muscle cells |
| Q34453782 | Basic fibroblast growth factor decreases type V/XI collagen expression in cultured bovine aortic smooth muscle cells |
| Q34228938 | Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts |
| Q35794835 | Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. |
| Q35026967 | Cell-mediated Delivery and Targeted Erosion of Vascular Endothelial Growth Factor-Crosslinked Hydrogels |
| Q71824995 | Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions |
| Q43977523 | Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia |
| Q46202171 | Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts. |
| Q33920258 | Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix |
| Q38572024 | Current status of biodegradable stents. |
| Q74107267 | Decreased adventitial neovascularization after intracoronary irradiation in swine: a time course study |
| Q38293159 | Designer protein delivery: From natural to engineered affinity-controlled release systems |
| Q33892025 | Development of fibrin derivatives for controlled release of heparin-binding growth factors |
| Q28254672 | Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries |
| Q33908328 | Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages |
| Q73407552 | Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery |
| Q37209651 | Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells |
| Q73589785 | Endothelial proteoglycans inhibit bFGF binding and mitogenesis |
| Q37380464 | Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. |
| Q34459530 | Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies |
| Q71797625 | Expression of CD11b and ICAM-1 in an in vivo model of transplant arteriosclerosis |
| Q42828363 | Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro |
| Q37284160 | Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice |
| Q33905997 | Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium |
| Q40664687 | Growth factors and arterial smooth muscle cell proliferation |
| Q32063006 | Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries |
| Q52224340 | Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. |
| Q43003667 | Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism |
| Q42113999 | Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells |
| Q35001204 | Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors |
| Q35201212 | Hydrogels for tissue engineering: scaffold design variables and applications |
| Q24320086 | Identification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation |
| Q71536905 | Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model |
| Q38135949 | Incorporation of heparin into biomaterials |
| Q37293928 | Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway. |
| Q35833010 | Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets |
| Q37209762 | Inflammatory angiogenesis in atherogenesis--a double-edged sword |
| Q71803367 | Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo |
| Q35544852 | Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers |
| Q50517658 | Inhibitory effect of methylene blue-induced photooxidation on intimal thickening of vein graft. |
| Q53900090 | Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. |
| Q40588222 | Lipoproteins and their functions |
| Q34133379 | Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty |
| Q73422916 | Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons |
| Q71807386 | Mechanisms of Transmural Heparin Transport in the Rat Abdominal Aorta After Local Vascular Delivery |
| Q73421764 | Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy |
| Q51599089 | Neointimal vascularization and intimal thickening in response to self-expanding stents: a swine model. |
| Q40342088 | Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques |
| Q73140029 | Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease |
| Q36111145 | Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition |
| Q38410604 | Pharmacology and controlled release of hirudin for cardiovascular disorders |
| Q51838403 | Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia. |
| Q35782751 | Postnatal regulation of fibroblast growth factor ligand and receptor gene expression in rat thoracic aorta |
| Q44117675 | Procurement regimens to reduce ischemia reperfusion injury of vascular grafts |
| Q33834873 | Quantification of vasa vasorum density in multi-slice computed tomographic coronary angiograms: role of computed tomographic image voxel size |
| Q27316848 | Recombinant IFN-α2a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-α2a in vivo and in vitro |
| Q34170606 | Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts |
| Q37624409 | Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass |
| Q34992542 | Restenosis after balloon angioplasty and/or stent insertion - origin and prevention |
| Q41478107 | Restenosis: is there a pharmacologic fix in the pipeline? |
| Q44922305 | Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT. |
| Q36689617 | Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing |
| Q37357738 | Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides |
| Q50941028 | Subharmonic contrast intravascular ultrasound for vasa vasorum imaging. |
| Q35767647 | Sustained inhibition of intimal thickening. In vitro and in vivo effects of polymeric beta-cyclodextrin sulfate |
| Q26822678 | The evolution of endothelial regulatory paradigms in cancer biology and vascular repair |
| Q36896406 | The role of the adventitia in vascular inflammation |
| Q47910562 | Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q33949676 | Tissue engineered perivascular endothelial cell implants regulate vascular injury |
| Q35040815 | Tissue engineering strategies for in vivo neovascularisation |
| Q37386687 | Tissue-engineered endothelial cell layers on surface-modified Ti for inhibiting in vitro platelet adhesion. |
| Q71813161 | Vasa vasorum: therapeutic implications |
| Q37479819 | Vascular regeneration: engineering the stem cell microenvironment |
Search more.